A drug named Cialis gained the U.S Food and Drug Administration’s (FDA) approval for treating erectile dysfunction (ED) way back in 2003. Now, the FDA has approved Cialis (tadalafil) for the treatment of benign prostatic hyperplasia (BPH) and ED when they occur simultaneously.
In 2 clinical tests, men suffering from BPH who received 5 milligrams of Cialis once a day seemed to encounter improvement in their problems, unlike those who were given placebo. The findings were based on International Prostate Symptom Score (IPSS).
In a subsequent study, men who faced both ED and BPH and who consumed 5mg of Cialis once a day apparently showed better results as compared to those who took placebo. The ED score was calculated with the help of the International Index of Erectile Function.
“BPH can have a big impact on a patient’s quality of life. A large number of older men have symptoms of BPH. Cialis offers these men another treatment option, particularly those who also have ED, which is also common in older men,” commented Scott Monroe, director of the Division of Reproductive and Urologic Products in the FDA’s Center for Drug Evaluation and Research.
However, Cialis should not be consumed by patients on nitrates or alpha blockers, the report states, as it is related to blood pressure drops. The list of drugs approved by FDA to treat symptoms of BPH include Proscar, (finasteride), Avodart (dutasteride), Jalyn (dutasteride plus tamsulosin), and the alpha blockers: Hytrin (terazosin), Cardura (doxazosin), Flomax (tamsulosin), Uroxatral (alfuzosin) and Rapaflo (silodosin).
Cialis is produced by Indianapolis-based Eli Lilly and Co.